IVF Near Staten Island, NY | Damien Fertility Partners
Patients evaluating fertility clinics want to know who manages their care at every stage, whether the lab holds independent accreditation, and what the published outcomes actually reflect. Those are the right questions.
Damien Fertility Partners has provided IVF treatment across New Jersey since 1989, with offices in Shrewsbury (Monmouth County), Newark (Essex County), and Jersey City (Hudson County). Our embryology lab holds accreditation from the College of American Pathologists (CAP), the FDA, and the NJ State Department of Health — all with zero deficiencies. The same board-certified physician stays with each patient through every consultation, monitoring visit, retrieval, and transfer.
Private Fertility Practice vs. Large IVF Centers
Physician continuity is one of the most clinically significant differences between a private practice and a high-volume center. At large clinics, care is frequently distributed across multiple providers — a different face at each monitoring visit, a different physician performing the retrieval. Research across more than 300 U.S. fertility clinics found no clear link between clinic volume and success rates, which means size is not a proxy for quality.
At our practice, the same ABOG board-certified reproductive endocrinologist oversees your care from the first consultation through transfer. This continuity matters most in complex or evolving cases, where nuanced decision-making depends on the physician knowing your full history — not reading it from a chart minutes before a procedure. It is the explicit contrast with practices that rotate providers, and it is central to how we define quality care.
CAP-Accredited Embryology Lab and AI Monitoring
Laboratory Accreditation That Underpins Every Cycle
IVF outcomes are closely tied to lab quality. Our embryology lab holds accreditation from the College of American Pathologists (CAP), the FDA, and the NJ State Department of Health — all with zero deficiencies. The lab is directed by Klaus Wiemer, PhD, HCLD, who brings over 40 years of clinical embryology experience and has authored more than 80 peer-reviewed publications.
CHLOE by Fairtility
The lab uses CHLOE by Fairtility, an AI-powered embryo monitoring system integrated into embryoscope time-lapse incubators. CHLOE enables continuous, non-invasive tracking of embryo development, giving our team real-time data to identify which embryos are best suited for transfer — without removing them from the controlled incubator environment.
The Physicians Behind Your Care
Dr. Miguel Damien — Founder and Medical Director. Dr. Damien founded the practice in 1989 — originally as East Coast IVF, establishing New Jersey’s first successful IVF program in Monmouth and Ocean County. He is a Dartmouth Medical School graduate who completed his OB/GYN residency and REI fellowships at Harvard Medical School and the University of Connecticut. Board-certified in REI by ABOG and fluent in Spanish, he has been named a Castle Connolly Top Doctor in the NY Metro Area six times (2005, 2007, 2008, 2010, 2017, 2018).
Dr. Barry Perlman — Board-Certified REI Specialist. Dr. Perlman is an ABOG board-certified REI specialist and Fellow of the American College of Obstetricians and Gynecologists (ACOG). A published researcher on endocrine disruptors and fertility, he has been named a Castle Connolly Top Doctor five times. He joined our practice in 2023 and offers both in-person and virtual consultations for Staten Island patients.
IUI vs. IVF: How Treatment Decisions Are Made
IVF is not the starting point for every patient. The American Society for Reproductive Medicine defines infertility as the failure to achieve pregnancy after 12 months of unprotected intercourse — or six months for women over 35 — and its clinical guidelines inform how we sequence treatment recommendations.
For patients with open fallopian tubes, near-normal sperm parameters, and responsive ovulation, IUI is often the clinically appropriate first step. Starting with IUI is not a compromise for the right patient — it is an evidence-based approach that preserves the option of IVF if needed, while avoiding a more intensive intervention before it is indicated.
IVF is recommended when IUI is unlikely to succeed. In cases of moderate to severe male factor infertility, IVF with intracytoplasmic sperm injection (ICSI) can assist fertilization in ways IUI cannot. A BMC Women’s Health literature review supports transitioning to IVF for women over 38 and for couples who have not conceived after multiple IUI cycles. A 2024 meta-analysis in Human Reproduction Update reinforces that the decision should be based on individual clinical factors — not a default assumption that IVF is always faster or more effective.
Each patient works with a dedicated, board-certified physician who evaluates the full clinical picture and recommends a treatment path grounded in evidence, not a standardized protocol.
IVF Outcomes: 2023 SART Reported Data
Federal Reporting Through the CDC and SART
IVF outcomes in the U.S. are not self-reported alone. Clinics must submit annual data to the CDC through the National ART Surveillance System (NASS), creating a standardized, public dataset. SART — the Society for Assisted Reproductive Technology — also publishes clinic-level outcomes, giving patients independently verified reference points when comparing clinics.
2023 Outcomes at Damien Fertility Partners
Live birth rate for patients under 35. In 2023 — the most recent SART reporting year — we reported an 81.8% live-birth rate per new patient for women under 35. These outcomes reflect real clinical results submitted through SART’s standardized framework. Full data across all age brackets is available on the SART website and our success rates page. Clinic-to-clinic comparisons should be interpreted with caution due to differences in patient populations.
Single embryo transfer as a standard of care. Our 100% elective single-embryo transfer (eSET) rate for patients under 35 means strong live-birth outcomes were achieved while actively minimizing the risk of multiple pregnancies — which carry elevated health risks for both mother and child. That clinical context is what makes the number meaningful.
The IVF Process, Step by Step
Consultation and diagnostic workup. Every IVF cycle begins with a comprehensive consultation. Your physician reviews your medical history, orders targeted diagnostics, and develops a treatment plan based on your specific clinical profile. Nothing is standardized; the plan reflects your individual situation.
Ovarian stimulation. Injectable medications prompt the ovaries to develop multiple follicles over roughly 10 to 14 days. Brief monitoring visits with ultrasound and bloodwork allow the physician to track development and adjust medications in real time.
Trigger shot and egg retrieval. When follicles reach target size, a trigger shot signals final egg maturation. Retrieval is performed under light sedation by our in-house surgical team — patients are not referred out. The procedure is minimally invasive and ultrasound-guided.
Fertilization and embryo development. Eggs are fertilized in our CAP-accredited lab. Embryo development is tracked continuously through CHLOE by Fairtility, with real-time data informing which embryos are best suited for transfer.
Embryo transfer. The transfer is a brief, in-office procedure that does not require anesthesia. For patients under 35, we perform elective single-embryo transfer (eSET) as standard practice. The transfer may occur within the same cycle or using frozen embryos — a decision made collaboratively between you and your physician based on clinical factors.
Continuity throughout. The same physician who opened the cycle performs the transfer. That continuity — from first consultation through final step — ensures every decision is informed by the full picture of your case.
Accessing Care from Staten Island
Our Jersey City location — at One Journal Square Plaza, Suite 301-A (Hudson County) — is the most accessible office for Staten Island residents, reachable via the Bayonne Bridge or through public transit connections. Dr. Perlman’s availability for virtual consultations means initial appointments, follow-up discussions, and treatment planning can all begin remotely before in-person monitoring and procedures are required.
Staten Island patients may also benefit from New Jersey’s fertility insurance mandate. The 2024 Murphy expansion requires group health insurance policies covering 50 or more employees to cover up to four completed egg retrievals per lifetime, with prior restrictions on age, relationship status, and sexual orientation removed. For patients whose employers fall under this mandate, coverage may apply regardless of which state the employer is based in — worth confirming with your insurer.
Request a consultation with Dr. Damien or Dr. Perlman to discuss your options. Visit damienfertilitypartners.com or call (732) 758-6511 to reach our scheduling team directly.
Frequently Asked Questions
1. Which Damien Fertility Partners location is most accessible from Staten Island?
Our Jersey City location at One Journal Square Plaza, Suite 301-A (Hudson County) is the most accessible for Staten Island residents, reachable via the Bayonne Bridge or public transit. Dr. Perlman also offers virtual consultations for initial appointments.
2. What is the difference between a private fertility practice and a large IVF center?
Private practices like ours offer physician continuity — the same ABOG board-certified REI specialist oversees your care from consultation through transfer. Research across more than 300 U.S. clinics found no link between clinic volume and success rates, making lab quality and physician continuity more meaningful factors than clinic size.
3. Who are the physicians at Damien Fertility Partners?
The practice is led by Dr. Miguel Damien, a Harvard-trained, board-certified REI specialist and six-time Castle Connolly Top Doctor (2005, 2007, 2008, 2010, 2017, 2018), and Dr. Barry Perlman, a board-certified REI Fellow of ACOG and published researcher on endocrine disruptors and fertility. Dr. Perlman offers both in-person and virtual consultations.
4. What are Damien Fertility Partners’ IVF success rates?
In 2023, we reported an 81.8% live-birth rate per new patient for women under 35, with a 100% eSET rate in that age group, as submitted through SART. Full data across all age groups is available on the SART website and our success rates page. Clinic-to-clinic comparisons should be interpreted with caution due to differences in patient populations.
5. Is the embryology lab accredited?
Yes. Our lab holds accreditation from the CAP, the FDA, and the NJ State Department of Health — all with zero deficiencies. It is directed by Klaus Wiemer, PhD, HCLD, with over 40 years of clinical embryology experience and more than 80 peer-reviewed publications. We use CHLOE by Fairtility for continuous, AI-powered embryo monitoring.
6. What is CHLOE, and how does it work?
CHLOE by Fairtility is an AI-powered embryo monitoring system integrated into our embryoscope time-lapse incubators. It tracks embryo development continuously and non-invasively, providing our embryology team with real-time data to support transfer decisions — without removing embryos from the controlled incubator environment.
7. Does Damien Fertility Partners offer virtual consultations?
Yes. Dr. Barry Perlman offers virtual consultations for patients who prefer to begin their care remotely. This is a practical starting point for Staten Island patients before traveling to our Jersey City location for monitoring or procedures. Call (732) 758-6511 or visit damienfertilitypartners.com to schedule.